Amgen Inc. (AMGN)
NASDAQ · Healthcare
Amgen Inc. Long Term Debt 2007–2025
Amgen Inc. annual long term debt history from 2009 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Amgen Inc. long term debt as of December 31, 2025: 54.60B, a 9.14% decrease year-over-year.
- Amgen Inc. long term debt for 2025 were 54.60B, a 9.14% decrease from 2024.
- Amgen Inc. long term debt for 2024 were 60.10B, a 6.99% decrease from 2023.
- Amgen Inc. long term debt for 2023 were 64.61B, a 65.91% increase from 2022.
- Amgen Inc. long term debt for 2022 were 38.95B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amgen Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $54,604 |
| 2024 | $60,099 |
| 2023 | $64,613 |
| 2022 | $38,945 |
| 2021 | $33,309 |
| 2020 | $32,986 |
| 2019 | $29,903 |
| 2018 | $33,929 |
| 2017 | $35,342 |
| 2016 | $34,596 |
| 2015 | $31,429 |
| 2014 | $30,715 |
| 2013 | $32,128 |
| 2012 | $26,529 |
| 2011 | $21,428 |
Amgen Inc. Long Term Debt — FAQ
Amgen Inc. (AMGN) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMGN's long term debt history?
The chart and table above show Amgen Inc.'s long term debt by year and by quarter, including the growth rate.